Useful pharmaceutical salts of 7-[(3R, 4R)-3-Hydroxy-4-hydroxymethyl-pyrroli din-1ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimi din-4-one

Details for Australian Patent Application No. 2010230008 (hide)

Owner BIOCRYST PHARMACEUTICALS, INC.

Inventors Bartley, Gary; Cleary, Thomas; Lang, John F.

Agent EF WELLINGTON & CO

Pub. Number AU-A-2010230008

PCT Pub. Number WO2010/111381

Priority 61/162,805 24.03.09 US

Filing date 24 March 2010

Wipo publication date 30 September 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/111381 Priority application(s): WO2010/111381

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010230009-Amelioration of heterophile antibody immunosensor interference

2010230007-Determining a position of a survey receiver in a body of water